Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GC 2107

Drug Profile

GC 2107

Alternative Names: CB02-0133; FXa inhibitor - LigaChem Biosciences; GC-2107; GC4401; GCC-2107; GCC-4401; GCC-4401C; I Fxa - LigaChem Biosciences; LCB-02-0133; Nokxaban

Latest Information Update: 08 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LegoChem Biosciences
  • Developer GC Biopharma; LigaChem Biosciences
  • Class Anticoagulants; Antithrombotics; Small molecules
  • Mechanism of Action Factor Xa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Embolism; Stroke; Venous thromboembolism

Most Recent Events

  • 29 Mar 2022 GC Pharma is now called GC Biopharma
  • 05 Apr 2021 No development reported - Phase-II for Embolism (Prevention) in USA (PO)
  • 05 Apr 2021 No development reported - Phase-II for Stroke (Prevention) in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top